Interactions ofΔ 11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographywith cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography
Agurell, S., Carlsson, S., Lindgren, J. E., Ohlsson, A., Gillespie, H., Hollister, L.·1981·Experientia
Cited by (129)
Items 101–129 of 129
- Medicinal Cannabis: an overview for health-care providersJason V. Wallach · 2020 · Elsevier eBooks
- RECENT STUDIES ON THE PHARMACOKINETICS OF DELTA-1-TETRAHYDROCANNABINOL IN MANStig Agurell, Jan‐Erik Lindgren, Agneta Ohlsson, H. K. Gillespie, Leo E. Hollister · 1984 · Elsevier eBooks
- The impact of cannabinoids on reproductive functionReese S Cameron, Genevieve A. Perono, Christian D Natale, Jim Petrik, Alison C. Holloway, Daniel Barry Hardy · 2025 · Reproduction
- 4′-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: Contribution of anti-inflammatory and anti-glutamatergic mechanismsMaurício dos Santos Pereira, Gabriel H Dias de Abreu, Leonardo Calaça Arruda Vanderlei, Rita Raisman‐Vozari, Francisco Silveira Guimarães, Hui‐Chen Lu, Patrick Pierre Michel, Elaine Aparecida Del Bel · 2024 · Neuropharmacology
- Establishment of a point of departure for CBD hepatotoxicity employing human HepaRG spheroidsJinpeng Li, Joseph Ward Zagorski, Norbert E. Kaminski · 2023 · Toxicology
- THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?Joanna Bartkowiak-Wieczorek, Edyta Mądry, Michał Książkiewicz, Jakub Winkler-Galicki, Milena Szalata, Marlena Szalata, Ulises Elizalde Jiménez, Karolina Wielgus, Edmund Grześkowiak, Ryszard Słomski et al. · 2023 · Nutrients
- Rapid high-performance liquid chromatographic assay with pharmacokinetic applications for monitoring cannabidiol in plasmaEmil E. Samara, Meir Bialer · 1987 · Journal of Chromatography B Biomedical Sciences and Applications
- Reassessing the Drug Potential of Industrial HempFranjo Grotenhermen, Gero Leson · 2002
- Interactions of Marihuana and THC with Other DrugsLeo E. Hollister · 1999 · Humana Press eBooks
- Analysis of the cannabinoidsDavid John Harvey · 1984 · Palgrave Macmillan UK eBooks
- Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and BehaviorSuhas Ganesh, Jose Cortes-Briones, Ashley M. Schnakenberg Martin, Patrick D. Skosnik, Deepak Cyril D’Souza, Mohini Ranganathan · 2022 · Cannabis and Cannabinoid Research
- Drug interactions with Cannabis sativa: Mechanisms and clinical implicationAtena Hasanpoor, Maryam Akaberi, Prashant Kesharwani, Zahra Sobhani, Amirhossein Sahebkar · 2023 · Annales de Toxicologie Analytique
- Cannabis and Driving: Developing Guidelines for Safety PoliciesFederico Manetti, Silvio Chericoni, Anna M. Marrocco, Matteo Scopetti, Martina Padovano, Alessandro Santurro, Paola Frati, Mario Gabbrielli, Vittorio Fineschi · 2022 · Current Pharmaceutical Biotechnology
- Cannabidiol – berauschend unberauschend?Gisela Skopp, Matthias Graw, Frank Mußhoff · 2022 · Rechtsmedizin
- Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic painYu Wang, Xinzhen Fu, Meihua Zheng, Qian Liu, Hailin Gan, Zeyu Song, Mingyan Yang, Ke Liu, Zeping Xie, Huaying Fan · 2024 · European Journal of Pain
- Phytocannabinoids: Cannabidiol (CBD)Priodarshi Roychoudhury, Ning Nan Wang, Samer Narouze · 2021 · Springer eBooks
- Dose- and tissue-dependent effects of cannabidiol on antioxidant status in developing chicken embryosRenata Muchacka · 2025 · Scientific Reports
- Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation StrategiesSilvia Afonso, Joana Gonçalves, Ana Teresa Brinca, Luana M. Rosendo, Tiago Rosado, Ana Paula Duarte, Eugénia Gallardo · 2026 · Diseases
- Pharmacokinetic Modeling of the “Nose-to-Brain” Pathway as Demonstrated by Intranasal Administration of Cannabidiol-Loaded NanoparticlesIlya Eydelman, Shimon Ben‐Shabat, Amnon C. Sintov · 2026 · Pharmaceuticals
- Adverse events associated with medical cannabis reported within a centralized call centerSílvia M. Illamola, Xintian Lyu, Monica M. Luciana, Stephen Dahmer, Paloma Lehfeldt, Sibel Dikmen, Inonge Kaloustian, Marné Garretson, Richard L. Kingston, Ilo E. Leppik et al. · 2026 · Frontiers in Pharmacology
- Models to Predict Cannabinoid-Induced DisturbancesH. Edery · 1983 · Archives of toxicology. Supplement
- Cannabinoids: Forensic Toxicology and TherapeuticsHelena M., Flávio Reis · 2011 · InTech eBooks
- Pharmacokinetics and Cognitive Side Effcets of Cannabidiol In Adult PatientsMiss. Akanksha N. Mote, Miss. Pratiksha B. Bhise, Miss. Rasika D. Chavan, Miss. Prapti P. Patil, Manohar D. Kengar · 2022 · International Journal of Advanced Research in Science Communication and Technology
- Marijuana, Liver Enzymes, and ToxicityLester M. Bornheim · 1991 · Humana Press eBooks
- Be aware that the use of tobacco, cannabinoids and smoking cessation may result in pharmacokinetic interactions with other drugsAdis Medical Writers · 2017 · Drugs & Therapy Perspectives
- Circadian Medicine: Cannabinoid Chronotherapy for Treatment of HypertensionAidan Murray · 2020 · The Atrium (University of Guelph)
- The Endocannabinoid System and Medicinal CannabisKylie O’Brien, Carolyn Bosak · 2025 · Springer eBooks
- Plasma cannabinoid pharmacokinetics following the inhalation of vaporised cannabis with and without cannabidiolDaniel Hall, Edward Chesney, Claire Mokrysz, Anna Caldwell, John M. Halket, Kat Petrilli, Matthew B. Wall, H. Valerie Curran, Tom P. Freeman, Will Lawn · 2026 · Drug and Alcohol Dependence
- PRECLINICAL DEVELOPMENT OF PHYTOCANNABINOID- AND ENDOCANNABINOID- BASED PHARMACOTHERAPIES FOR THE TREATMENT OF ETHANOL-INDUCED NEURODEGENERATIONDaniel J. Liput · 2013 · UKnowledge (University of Kentucky)
